AU2012310880B2 - Antibody against affinity complex - Google Patents

Antibody against affinity complex Download PDF

Info

Publication number
AU2012310880B2
AU2012310880B2 AU2012310880A AU2012310880A AU2012310880B2 AU 2012310880 B2 AU2012310880 B2 AU 2012310880B2 AU 2012310880 A AU2012310880 A AU 2012310880A AU 2012310880 A AU2012310880 A AU 2012310880A AU 2012310880 B2 AU2012310880 B2 AU 2012310880B2
Authority
AU
Australia
Prior art keywords
antibody
affinity complex
vitamin
complex
affinity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2012310880A
Other languages
English (en)
Other versions
AU2012310880A1 (en
Inventor
Tsuyoshi Ando
Katsutoshi GOISHI
Asako Oka
Kazuya Omi
Takuya SAKYU
Takashi Shirakawa
Yoshiaki Uchida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Inc
Original Assignee
Fujirebio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujirebio Inc filed Critical Fujirebio Inc
Publication of AU2012310880A1 publication Critical patent/AU2012310880A1/en
Application granted granted Critical
Publication of AU2012310880B2 publication Critical patent/AU2012310880B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/32—Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2012310880A 2011-09-21 2012-07-04 Antibody against affinity complex Ceased AU2012310880B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2011-206162 2011-09-21
JP2011206162 2011-09-21
JP2012-006359 2012-01-16
JP2012006359 2012-01-16
PCT/JP2012/067062 WO2013042426A1 (ja) 2011-09-21 2012-07-04 親和性複合体に対する抗体

Publications (2)

Publication Number Publication Date
AU2012310880A1 AU2012310880A1 (en) 2014-04-10
AU2012310880B2 true AU2012310880B2 (en) 2015-12-03

Family

ID=47914207

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012310880A Ceased AU2012310880B2 (en) 2011-09-21 2012-07-04 Antibody against affinity complex

Country Status (13)

Country Link
US (1) US9599608B2 (cg-RX-API-DMAC7.html)
EP (1) EP2759551B1 (cg-RX-API-DMAC7.html)
JP (1) JP6156144B2 (cg-RX-API-DMAC7.html)
KR (1) KR101720394B1 (cg-RX-API-DMAC7.html)
CN (1) CN103827145A (cg-RX-API-DMAC7.html)
AU (1) AU2012310880B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014006405A2 (cg-RX-API-DMAC7.html)
CA (1) CA2849274C (cg-RX-API-DMAC7.html)
IL (1) IL231404A0 (cg-RX-API-DMAC7.html)
IN (1) IN2014CN02113A (cg-RX-API-DMAC7.html)
RU (1) RU2014115676A (cg-RX-API-DMAC7.html)
TW (1) TW201313743A (cg-RX-API-DMAC7.html)
WO (1) WO2013042426A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10983136B2 (en) 2013-01-28 2021-04-20 Diasorin S.P.A. Use of 1,25-dihydroxyvitamin D values in ratio with PTH as a prognostic biomarker
PT2759550T (pt) 2013-01-28 2018-11-16 Diasorin S P A Método e kit para detetar 1,25-di-hidroxivitamina d e anticorpos relacionados
US11261257B2 (en) 2013-01-28 2022-03-01 Diasorin S.P.A. Methods for detecting 1,25-dihydroxyvitamin D and related antibodies
JP6281497B2 (ja) 2013-02-06 2018-02-21 富士レビオ株式会社 ビタミンｄの測定方法および測定用キット
TW201536801A (zh) * 2014-02-25 2015-10-01 Fujirebio Kk 改質單體ＩｇＭ
CA3047691C (en) 2015-12-21 2022-12-06 Turun Yliopisto Antibodies against immunocomplexes comprising cyanobacterial cyclic peptide hepatotoxins
KR20180104080A (ko) * 2016-01-22 2018-09-19 아피메딕스, 인코포레이티드 비타민 d 대사산물 검출용 장치
CN106244562B (zh) * 2016-05-20 2019-07-23 杭州奥泰生物技术股份有限公司 杂交瘤细胞株及其分泌的抗25羟基维生素d3单克隆抗体和应用
US11435367B2 (en) * 2016-07-29 2022-09-06 Diazyme Laboratories, Inc. Methods and kits for assaying a vitamin D moiety
EP3624811A4 (en) * 2017-05-19 2021-03-10 The Regents of The University of California ANTIBODY-BASED CHEMICAL INDUCED DIMERIZER (ABCID) AS A MOLECULAR SWITCH FOR REGULATING CELL THERAPIES
JP7325336B2 (ja) 2017-12-25 2023-08-14 富士レビオ株式会社 マクロライド系免疫抑制剤についての血液検査方法
JP7434824B2 (ja) * 2019-11-20 2024-02-21 東ソー株式会社 抗イムノコンプレックス抗体を用いた測定方法
CN114746754A (zh) * 2019-11-20 2022-07-12 东曹株式会社 使用抗免疫复合物抗体的测定方法
JP7683188B2 (ja) * 2019-11-29 2025-05-27 東ソー株式会社 抗イムノコンプレックス抗体を用いた測定法
CN113125696B (zh) * 2019-12-31 2024-03-26 科美博阳诊断技术(上海)有限公司 一种雌二醇均相化学发光检测试剂盒及其应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4840895A (en) * 1984-03-30 1989-06-20 Cambridge Patent Development Limited Monoclonal antibodies reactive with immune complexes
JP2001174460A (ja) * 1999-12-17 2001-06-29 Tosoh Corp 免疫測定方法および免疫測定試薬
WO2004046733A1 (en) * 2002-11-18 2004-06-03 Valtion Teknillinen Tutkimuskeskus Non-competitive immunoassay for small analytes
WO2008125733A1 (en) * 2007-04-13 2008-10-23 Hytest Ltd. Immunoassay for quantification of an unstable antigen selected from bnp and probnp
WO2009150295A1 (en) * 2008-06-12 2009-12-17 Valtion Teknillinen Tutkimuskeskus Detection of cannabis use

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0091760B1 (en) * 1982-04-09 1986-07-02 FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. Anti immune complex antibody and preparation thereof
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5807715A (en) * 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5223441A (en) * 1986-10-09 1993-06-29 Syntex (U.S.A.) Inc. Receptors for immune complexes
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5413923A (en) 1989-07-25 1995-05-09 Cell Genesys, Inc. Homologous recombination for universal donor cells and chimeric mammalian hosts
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
US5187065A (en) * 1989-12-22 1993-02-16 Schutzer Steven E Method and materials for detecting lyme disease
DE69133566T2 (de) 1990-01-12 2007-12-06 Amgen Fremont Inc. Bildung von xenogenen Antikörpern
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
WO1992003918A1 (en) 1990-08-29 1992-03-19 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5814318A (en) 1990-08-29 1998-09-29 Genpharm International Inc. Transgenic non-human animals for producing heterologous antibodies
DE69233482T2 (de) 1991-05-17 2006-01-12 Merck & Co., Inc. Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
DE69233745D1 (de) 1991-12-02 2008-10-23 Cambridge Antibody Tech Herstellung von Autoantikörpern auf Phagenoberflächen ausgehend von Antikörpersegmentbibliotheken
PL171749B1 (pl) 1992-06-09 1997-06-30 Hoppe Ag Zamek zatrzaskowypopychacz , wspólpracujacy z lukowym wglebie- PL PL PL PL
US5639641A (en) 1992-09-09 1997-06-17 Immunogen Inc. Resurfacing of rodent antibodies
ATE390933T1 (de) 1995-04-27 2008-04-15 Amgen Fremont Inc Aus immunisierten xenomäusen stammende menschliche antikörper gegen il-8
WO1996034096A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5916771A (en) 1996-10-11 1999-06-29 Abgenix, Inc. Production of a multimeric protein by cell fusion method
CA2722378C (en) 1996-12-03 2015-02-03 Amgen Fremont Inc. Human antibodies that bind tnf.alpha.
AU6118998A (en) 1997-02-28 1998-09-18 Kirin Beer Kabushiki Kaisha Pluripotent cells having disrupted intrinsic genes
TWI255853B (en) 1998-08-21 2006-06-01 Kirin Brewery Method for modifying chromosomes
US7122339B2 (en) 1998-10-09 2006-10-17 Medical Research Council Method for generating diversity
EP1190042A2 (en) 1999-06-04 2002-03-27 Tranxenogen, Inc. Methods for manipulating the avian genome
JP2001231403A (ja) 2000-02-18 2001-08-28 Kirin Brewery Co Ltd 改変された外来染色体あるいはその断片を保持する非ヒト動物
CN1486365B (zh) 2000-11-17 2010-05-12 协和发酵麒麟株式会社 异种(人类)免疫球蛋白在克隆转基因有蹄类动物中的表达
ES2645563T3 (es) 2001-11-30 2017-12-05 Amgen Fremont Inc. Animales transgénicos que portan genes de cadena ligera de Ig humana
PL373256A1 (en) 2002-04-09 2005-08-22 Kyowa Hakko Kogyo Co, Ltd. Cells with modified genome
CN100379862C (zh) 2002-07-30 2008-04-09 独立行政法人理化学研究所 增强体细胞同源重组的方法和构建特异抗体的方法
JP5319863B2 (ja) 2002-12-26 2013-10-16 独立行政法人理化学研究所 体細胞相同組換えの誘発方法
EP1749102A4 (en) 2004-04-22 2009-02-25 Kirin Pharma Kk TRANSGENIC ANIMALS AND USES THEREOF
WO2006047367A2 (en) 2004-10-22 2006-05-04 Therapeutic Human Polyclonals, Inc. Suppression of endogenous immunoglubolin expression in non-human transgenic animals
JP4892717B2 (ja) 2005-03-31 2012-03-07 国立大学法人広島大学 ニワトリキメラ抗体およびその利用
ES2323900T3 (es) * 2005-09-29 2009-07-27 F. Hoffmann-La Roche Ag Anticuerpos contra la 25-hidroxivitamina d.
JP2009082033A (ja) 2007-09-28 2009-04-23 Kaneka Corp 完全ヒト型抗体生産法
US20110097733A1 (en) * 2009-10-27 2011-04-28 Michel Anciaux Process for the production of a hybridoma and antibody obtained therefrom, able to recognize more than one vitamin d metabolite

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4840895A (en) * 1984-03-30 1989-06-20 Cambridge Patent Development Limited Monoclonal antibodies reactive with immune complexes
JP2001174460A (ja) * 1999-12-17 2001-06-29 Tosoh Corp 免疫測定方法および免疫測定試薬
WO2004046733A1 (en) * 2002-11-18 2004-06-03 Valtion Teknillinen Tutkimuskeskus Non-competitive immunoassay for small analytes
WO2008125733A1 (en) * 2007-04-13 2008-10-23 Hytest Ltd. Immunoassay for quantification of an unstable antigen selected from bnp and probnp
WO2009150295A1 (en) * 2008-06-12 2009-12-17 Valtion Teknillinen Tutkimuskeskus Detection of cannabis use

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
NAGATA S, et al. Natural Toxins, (1999) Vol 7, pp 49-55. *
SELF CH, et al. Clin Chem, (1994) Vol 40, pp 2035-2041. *
TOWBIN H, et al. Journal of Immunological Methods, (1995) Vol 181, pp 167-176. *

Also Published As

Publication number Publication date
WO2013042426A1 (ja) 2013-03-28
EP2759551A1 (en) 2014-07-30
BR112014006405A2 (pt) 2017-04-04
KR101720394B1 (ko) 2017-03-27
JP6156144B2 (ja) 2017-07-05
EP2759551A4 (en) 2015-03-04
US9599608B2 (en) 2017-03-21
RU2014115676A (ru) 2015-10-27
EP2759551B1 (en) 2019-05-22
CN103827145A (zh) 2014-05-28
AU2012310880A1 (en) 2014-04-10
IL231404A0 (en) 2014-04-30
CA2849274C (en) 2018-12-04
TW201313743A (zh) 2013-04-01
IN2014CN02113A (cg-RX-API-DMAC7.html) 2015-05-29
US20150037813A1 (en) 2015-02-05
JPWO2013042426A1 (ja) 2015-03-26
KR20140044940A (ko) 2014-04-15
CA2849274A1 (en) 2013-03-28

Similar Documents

Publication Publication Date Title
AU2012310880B2 (en) Antibody against affinity complex
US9890214B2 (en) Antibodies to TNF α and use thereof
JP2021531826A (ja) 栄養膜細胞表面抗原２（ｔｒｏｐ２）に対する特異的な抗体
KR20200061320A (ko) 세포독성 t-림프구-관련 단백질 4 (ctla-4)에 대한 신규의 단일클론 항체
JP7623939B2 (ja) 葉酸受容体アルファに特異的な抗体
CN116710136A (zh) Prame结合性分子
US20220298257A1 (en) Anti-cd22 antibodies and uses thereof
US20220289843A1 (en) Anti-cd19 antibodies and uses thereof
WO2020156507A1 (zh) 抗pd-l1的新型抗体及其用途
US20250277038A1 (en) Anti-pd-l1 antibody and use thereof
EP4293046A1 (en) Anti-pd-1 antibody and use thereof
HK40039327A (en) Antibodies specific to cd47 and pd-l1

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired